Human iPSC modeling recapitulates in vivo sympathoadrenal development and reveals an aberrant developmental subpopulation in familial neuroblastoma
Stéphane Van Haver(Ghent University), Stephen S. Roberts(Memorial Sloan Kettering Cancer Center)
Cited by 8
Related Papers
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition
|Science Advances|2022|49
5-day/5-drug myeloablative outpatient regimen for resistant neuroblastoma
|Bone Marrow Transplantation|2012|6